• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

易损斑块的诊断、临床影响及管理展望

Perspectives in the Diagnosis, Clinical Impact, and Management of the Vulnerable Plaque.

作者信息

Alperi Alberto, Antuna Paula, Almendárez Marcel, Álvarez Rut, Del Valle Raquel, Pascual Isaac, Hernández-Vaquero Daniel, Avanzas Pablo

机构信息

Hospital Universitario Central de Asturias, Oviedo, 33011 Asturias, Spain.

Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Asturias, Spain.

出版信息

J Clin Med. 2025 Feb 25;14(5):1539. doi: 10.3390/jcm14051539.

DOI:10.3390/jcm14051539
PMID:40095464
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11899957/
Abstract

Coronary artery disease is a highly prevalent disease that constitutes the leading cause of mortality worldwide. Acute coronary syndromes are the most devastating form of presentation of coronary disease, involving the acute formation of a thrombus within the coronary vessel lumen, further leading to flow limitation and diminished myocardial perfusion. Vulnerable plaques, which are characterized by thin-cap fibroatheroma, a large lipid pool, and macrophage infiltration and spotty calcification of the cap, pose a higher risk of coronary events despite not being flow-limiting. Iterations in intravascular imaging and coronary computed tomography have largely increased the ability to detect and define vulnerable plaques, and its clinical impact in early- and mid-term outcomes has been confirmed in several studies. In this review, we aimed to revise the current concept of vulnerable coronary plaque and its repercussion, to summarize the main pharmacological approaches for its management, and to provide an updated overview of the available evidence on preventive percutaneous interventional strategies in this clinical setting.

摘要

冠状动脉疾病是一种高度流行的疾病,是全球范围内主要的死亡原因。急性冠状动脉综合征是冠心病最具破坏性的表现形式,涉及冠状动脉管腔内血栓的急性形成,进而导致血流受限和心肌灌注减少。易损斑块的特征是薄帽纤维粥样斑块、大脂质池、巨噬细胞浸润以及帽部散在钙化,尽管不会造成血流受限,但发生冠状动脉事件的风险更高。血管内成像和冠状动脉计算机断层扫描技术的不断发展,极大地提高了检测和定义易损斑块的能力,多项研究已证实其对早期和中期结果的临床影响。在本综述中,我们旨在修订易损冠状动脉斑块的当前概念及其影响,总结其管理的主要药理学方法,并提供关于该临床环境中预防性经皮介入策略现有证据的最新概述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a13/11899957/8137efd197ec/jcm-14-01539-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a13/11899957/df5813df8b60/jcm-14-01539-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a13/11899957/d4f097fbf8df/jcm-14-01539-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a13/11899957/8137efd197ec/jcm-14-01539-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a13/11899957/df5813df8b60/jcm-14-01539-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a13/11899957/d4f097fbf8df/jcm-14-01539-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a13/11899957/8137efd197ec/jcm-14-01539-g003.jpg

相似文献

1
Perspectives in the Diagnosis, Clinical Impact, and Management of the Vulnerable Plaque.易损斑块的诊断、临床影响及管理展望
J Clin Med. 2025 Feb 25;14(5):1539. doi: 10.3390/jcm14051539.
2
Preventive PCI or medical therapy alone for vulnerable atherosclerotic coronary plaque: Rationale and design of the randomized, controlled PREVENT trial.针对易损性动脉粥样硬化冠状动脉斑块的预防性经皮冠状动脉介入治疗(PCI)或单纯药物治疗:随机对照PREVENT试验的原理与设计
Am Heart J. 2023 Oct;264:83-96. doi: 10.1016/j.ahj.2023.05.017. Epub 2023 Jun 2.
3
Management of Coronary Vulnerable Plaque With Medical Therapy or Local Preventive Percutaneous Coronary Intervention.药物治疗或局部预防性经皮冠状动脉介入治疗冠状动脉易损斑块
JACC Asia. 2024 May 28;4(6):425-443. doi: 10.1016/j.jacasi.2024.04.001. eCollection 2024 Jun.
4
Multimodal Intravascular Imaging of the Vulnerable Coronary Plaque.易损性冠状动脉斑块的多模态血管内影像学检查
Echocardiography. 2024 Nov;41(12):e70035. doi: 10.1111/echo.70035.
5
Role of Intravascular Ultrasound in Patients with Acute Myocardial Infarction.血管内超声在急性心肌梗死患者中的作用
Korean Circ J. 2015 Jul;45(4):259-65. doi: 10.4070/kcj.2015.45.4.259. Epub 2015 Jul 16.
6
Atherosclerotic plaque characterization by CT angiography for identification of high-risk coronary artery lesions: a comparison to optical coherence tomography.通过CT血管造影对动脉粥样硬化斑块进行特征分析以识别高危冠状动脉病变:与光学相干断层扫描的比较
Eur Heart J Cardiovasc Imaging. 2015 Apr;16(4):373-9. doi: 10.1093/ehjci/jeu188. Epub 2014 Sep 21.
7
Vulnerable Plaque in Patients with Acute Coronary Syndrome: Identification, Importance, and Management.急性冠状动脉综合征患者的易损斑块:识别、重要性及管理
US Cardiol. 2022 Jan 26;16:e01. doi: 10.15420/usc.2021.22. eCollection 2022.
8
[Vulnerable atherosclerotic plaques of coronary arteries in patients with stable coronary artery disease: 12-months follow-up].[稳定型冠状动脉疾病患者冠状动脉易损动脉粥样硬化斑块:12个月随访]
Kardiologiia. 2019 Nov 6;60(2):69-74. doi: 10.18087/cardio.2020.2.n467.
9
Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial.预防性经皮冠状动脉介入治疗与单纯最佳药物治疗治疗易损动脉粥样硬化性冠状动脉斑块(PREVENT):一项多中心、开放标签、随机对照试验。
Lancet. 2024 May 4;403(10438):1753-1765. doi: 10.1016/S0140-6736(24)00413-6. Epub 2024 Apr 8.
10
The vulnerable plaque: the real villain in acute coronary syndromes.易损斑块:急性冠状动脉综合征中的真正元凶。
Open Cardiovasc Med J. 2011;5:123-9. doi: 10.2174/1874192401105010123. Epub 2011 May 13.

本文引用的文献

1
Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial.光学相干断层成像术评价秋水仙碱对急性冠状动脉综合征患者冠脉斑块稳定性的影响:COLOCT 随机临床试验。
Circulation. 2024 Sep 24;150(13):981-993. doi: 10.1161/CIRCULATIONAHA.124.069808. Epub 2024 Aug 21.
2
SCAI Expert Consensus Statement on the Management of Calcified Coronary Lesions.SCAI关于钙化冠状动脉病变管理的专家共识声明
J Soc Cardiovasc Angiogr Interv. 2024 Jan 31;3(2):101259. doi: 10.1016/j.jscai.2023.101259. eCollection 2024 Feb.
3
Glucagon-like Peptide-1 analogues and delipidation of coronary atheroma in statin-treated type 2 diabetic patients with coronary artery disease: The prespecified sub-analysis of the OPTIMAL randomized clinical trial.
胰高血糖素样肽-1类似物与他汀类药物治疗的2型糖尿病合并冠心病患者冠状动脉粥样硬化的脂质清除:OPTIMAL随机临床试验的预设亚组分析。
Atheroscler Plus. 2024 Apr 4;56:1-6. doi: 10.1016/j.athplu.2024.03.001. eCollection 2024 Jun.
4
Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial.预防性经皮冠状动脉介入治疗与单纯最佳药物治疗治疗易损动脉粥样硬化性冠状动脉斑块(PREVENT):一项多中心、开放标签、随机对照试验。
Lancet. 2024 May 4;403(10438):1753-1765. doi: 10.1016/S0140-6736(24)00413-6. Epub 2024 Apr 8.
5
Percutaneous coronary intervention for non-obstructive vulnerable plaques.非阻塞性易损斑块的经皮冠状动脉介入治疗
Lancet. 2024 May 4;403(10438):1724-1725. doi: 10.1016/S0140-6736(24)00488-4. Epub 2024 Apr 8.
6
Coronary Plaque Characteristics Associated With Major Adverse Cardiovascular Events in Atherosclerotic Patients and Lesions: A Systematic Review and Meta-Analysis.与动脉粥样硬化患者和病变相关的主要不良心血管事件的冠状动脉斑块特征:系统评价和荟萃分析。
JACC Cardiovasc Imaging. 2023 Dec;16(12):1584-1604. doi: 10.1016/j.jcmg.2023.08.006. Epub 2023 Oct 4.
7
The plaque hypothesis: understanding mechanisms of plaque progression and destabilization, and implications for clinical management.斑块假说:理解斑块进展和不稳定的机制,及其对临床管理的意义。
Curr Opin Cardiol. 2023 Nov 1;38(6):496-503. doi: 10.1097/HCO.0000000000001077. Epub 2023 Aug 28.
8
First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP Study.首例人体药物洗脱球囊治疗易损富脂斑块:DEBuT-LRP研究的原理与设计
J Clin Med. 2023 Sep 6;12(18):5807. doi: 10.3390/jcm12185807.
9
Case report: Strong low-density-cholesterol reduction accompanied by shrinkage of low-attenuation coronary plaque during lipid-lowering treatment with bempedoic acid-serial evaluation by coronary computed tomography angiography.病例报告:在使用贝派地酸进行降脂治疗期间,通过冠状动脉计算机断层扫描血管造影进行系列评估,低密度脂蛋白胆固醇显著降低,同时低密度衰减冠状动脉斑块缩小。
Front Cardiovasc Med. 2023 Aug 4;10:1203832. doi: 10.3389/fcvm.2023.1203832. eCollection 2023.
10
Coronary Atherosclerotic Plaque Activity and Future Coronary Events.冠状动脉粥样硬化斑块活性与未来的冠状动脉事件。
JAMA Cardiol. 2023 Aug 1;8(8):755-764. doi: 10.1001/jamacardio.2023.1729.